Literature DB >> 19788602

Bone marrow stem cells and the liver: are they relevant?

Mélanie A Eckersley-Maslin1, Fiona J Warner, Candice A Grzelak, Geoffrey W McCaughan, Nicholas A Shackel.   

Abstract

The contribution of bone marrow stem cell responses to liver homeostasis, injury and malignancy is discussed in this review. Pluripotent stem cells or their more committed progenitor progeny are essential to tissue development, regeneration and repair and are widely implicated in the pathogenesis of malignancy. Stem cell responses to injury are the focus of intense research efforts in the hope of future therapeutic manipulation. Stem cells occur within tissues, such as the liver, or arise from extrahepatic sites, in particular, the bone marrow. As the largest reservoir of stem cells in the adult, the bone marrow has been implicated in the stem cell response associated with liver injury. However, in liver injury, the relative contribution of bone marrow stem cells compared to intrahepatic progenitor responses is poorly characterized. Intrahepatic progenitor responses have been recently reviewed elsewhere. In this review, we have summarized liver-specific extrahepatic stem cell responses originating from the bone marrow. The physiological relevance of bone marrow stem cell responses to adult liver homeostasis, injury and malignancy is discussed with emphasis on mechanisms of bone marrow stem cell recruitment to sites of liver injury and its contribution to intrahepatic malignancy.

Entities:  

Mesh:

Year:  2009        PMID: 19788602     DOI: 10.1111/j.1440-1746.2009.06004.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children.

Authors:  M Pillon; N S Carucci; C Mainardi; E Carraro; M Zuliani; L Chemello; E Calore; M Tumino; S Varotto; T Toffolutti; R Destro; M V Gazzola; R Alaggio; G Basso; C Messina
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

2.  CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.

Authors:  Changjun Zeng; Yanling Zhang; Su Cheol Park; Jong Ryeol Eun; Ngoc Tue Nguyen; Benjamin Tschudy-Seney; Yong Jin Jung; Neil D Theise; Mark A Zern; Yuyou Duan
Journal:  Stem Cells Dev       Date:  2015-08-19       Impact factor: 3.272

3.  Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas.

Authors:  Su Cheol Park; Ngoc Tue Nguyen; Jong Ryeol Eun; Yanling Zhang; Yong Jin Jung; Benjamin Tschudy-Seney; Artem Trotsyuk; Alexander Lam; Rajendra Ramsamooj; Yanghong Zhang; Neil D Theise; Mark A Zern; Yuyou Duan
Journal:  Stem Cells Dev       Date:  2015-01-26       Impact factor: 3.272

4.  Stem cell-based therapies for liver diseases: state of the art and new perspectives.

Authors:  Anna Chiara Piscaglia; Mariachiara Campanale; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Stem Cells Int       Date:  2010-09-01       Impact factor: 5.443

5.  Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.

Authors:  John M Gemery; Andrew R Forauer; Anne M Silas; Eric K Hoffer
Journal:  BMC Hematol       Date:  2016-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.